Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapy. (2012)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1089/hgtb.2011.170

PubMed Identifier: 22428979

Publication URI: http://europepmc.org/abstract/MED/22428979

Type: Journal Article/Review

Volume: 23

Parent Publication: Human gene therapy methods

Issue: 1

ISSN: 1946-6536